Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
0.207
-0.003 (-1.35%)
Nov 21, 2024, 11:29 AM EST - Market open
Bionano Genomics Revenue
Bionano Genomics had revenue of $6.07M in the quarter ending September 30, 2024, a decrease of -34.83%. This brings the company's revenue in the last twelve months to $33.33M, down -0.82% year-over-year. In the year 2023, Bionano Genomics had annual revenue of $36.12M with 29.90% growth.
Revenue (ttm)
$33.33M
Revenue Growth
-0.82%
P/S Ratio
0.44
Revenue / Employee
$96,901
Employees
344
Market Cap
19.62M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Concord Medical Services Holdings | 64.91M |
Bolt Biotherapeutics | 9.78M |
NeuroOne Medical Technologies | 3.92M |
NeurAxis | 2.46M |
Apollomics | 2.10M |
CytoMed Therapeutics | 330.25K |
BNGO News
- 7 days ago - Bionano Genomics, Inc. (BNGO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress - GlobeNewsWire
- 17 days ago - Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry - GlobeNewsWire
- 20 days ago - Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 21 days ago - Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 - GlobeNewsWire
- 6 weeks ago - Bionano Announces Preliminary 3Q 2024 Revenues and Cash - GlobeNewsWire
- 3 months ago - Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript) - Seeking Alpha
- 3 months ago - Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript - Seeking Alpha